Key result
COVID-19 infection and mRNA vaccines are linked to cardiovascular complications including myocarditis.
Why the study?
A significant number of COVID patients develop cardiac injury, making it of primary importance to understand its pathophysiology, complications, preventive care, and treatment.
This article reviews the cardiovascular complications of COVID-19, particularly myocarditis, and highlights a case of cardiac injury occurring during infection shortly after mRNA vaccination.
Answers are grounded in this paper and cite their sources.
Cardiac monitoring remains prudent in COVID-19; leaves open any interaction with recent mRNA vaccination pending higher-level evidence.
The WHO declared COVID 19 a global pandemic on March 11, 2020. The effect the virus has created in various aspects of our lives has made it of primary importance that we understand its pathophysiology, complication, preventive care, and treatment. A significant number of COVID patients develop some form of cardiac injury, whether while infected or after recovery. In this article, we aim to discuss these aspects and expand further on the cardiovascular effects seen in COVID 19 infected patients, emphasizing myocarditis. We discuss the case of a patient who developed cardiac injuries while infected with COVID 19, which she contacted 18 days after receiving the first dose of the COVID mRNA vaccine. This article provides more understanding of the relationship between COVID-19 and the heart.
No takes yet. Share an insight, caveat, or question.
Chovwen et al. (2021) conducted a review in COVID-19 and myocarditis. COVID-19 infection was evaluated. COVID-19 infection can cause cardiovascular complications like myocarditis, as seen in a patient who developed cardiac injury 18 days after her first mRNA vaccine dose.
Synapse has enriched 10 related papers. Consider them for comparative context: